Compare · PBAX vs SONO
PBAX vs SONO
Side-by-side comparison of Phoenix Biotech Acquisition Corp. (PBAX) and Sonos Inc. (SONO): market cap, price performance, sector, and recent activity on the wire.
Summary
- PBAX operates in Industrials, while SONO operates in Consumer Staples - the two are in different parts of the market.
- SONO is the larger of the two at $1.78B, about 7.8x PBAX ($227.7M).
- SONO has hit the wire 1 time in the past 4 weeks while PBAX has been quiet.
- SONO has more recent analyst coverage (12 ratings vs 0 for PBAX).
- Company
- Phoenix Biotech Acquisition Corp.
- Sonos Inc.
- Price
- $5.45+14.26%
- $14.74+2.25%
- Market cap
- $227.7M
- $1.78B
- 1M return
- -
- +11.08%
- 1Y return
- -
- +60.74%
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 0
- 1
- Recent ratings
- 0
- 12
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Sonos Inc.
Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells multi-room audio products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides wireless speakers, home theater speakers, components, and accessories. It offers its products through approximately 10,000 third-party retail stores, including custom installers of home audio systems; and e-commerce retailers, as well as through its Website sonos.com. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was founded in 2002 and is headquartered in Santa Barbara, California.
Latest PBAX
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
- Phoenix Biotech Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Leadership Update, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)
- New insider Corey Daniel claimed ownership of 671,470 shares (SEC Form 3) (Amendment)
- SEC Form D filed by Phoenix Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- SEC Form 4 filed by Laporte Kathleen (Amendment)
- Atwood Brian G acquired 248,735 shares (SEC Form 4) (Amendment)
- SEC Form SC 13D/A filed by Phoenix Biotech Acquisition Corp. (Amendment)
- Loewy Caroline M acquired 5,828 shares (SEC Form 4)
- Kosacz Barbara acquired 5,828 shares (SEC Form 4)
Latest SONO
- Sonos Announces Date for Second Quarter Fiscal 2026 Financial Results and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Sonos Inc.
- Large owner Coliseum Capital Management, Llc bought $3,068,690 worth of shares (228,920 units at $13.41) (SEC Form 4)
- Large owner Coliseum Capital Management, Llc bought $12,959,400 worth of shares (920,000 units at $14.09) (SEC Form 4)
- Director Genachowski Julius gifted 15,427 shares and received a gift of 15,427 shares, decreasing direct ownership by 22% to 53,775 units (SEC Form 4)
- Sonos Returns to the System That Built the Brand with Two Essential Speakers That Deliver Effortless Sound Throughout the Home
- Director Mildenhall Jonathan was granted 12,725 shares, increasing direct ownership by 46% to 40,272 units (SEC Form 4)
- Director Kennedy Joseph Jude was granted 12,725 shares, increasing direct ownership by 776% to 14,364 units (SEC Form 4)
- Director Genachowski Julius was granted 17,497 shares, increasing direct ownership by 34% to 69,202 units (SEC Form 4)
- Director Fields Mandy J was granted 12,725 shares, increasing direct ownership by 776% to 14,364 units (SEC Form 4)